About
Hing C. Wong, PhD, is the founder and CEO of HCW Biologics, a public biotech developing immunotherapies aimed at chronic inflammation, aging-related disease, and healthspan. Before HCW, he founded Altor BioScience and Sunol Molecular, and later served as CEO of NantCell after Altor's 2017 acquisition. Company materials credit him with leading the invention and development of ALT-803, now marketed as Anktiva.
Areas of interest
longevitybiotechimmunotherapyaging biologyhealthspanchronic inflammationoncology